You’ve probably seen BPC-157 mentioned in forums, podcasts, or that one friend who swears it fixed their nagging shoulder injury. You got curious. You did some research. And then you hit the wall that everyone hits: nobody can agree on how much to actually take.

Some people say 250 mcg twice daily. Others swear by 500 mcg once a day. A few brave souls report taking much higher amounts. Meanwhile, the studies everyone cites used rats, not humans, and the math to convert those doses gets confusing fast.

So what’s the deal with BPC-157 dosage? Let’s break down what we actually know, what we’re guessing at, and how people are making these decisions in the real world.

What even is BPC-157, and why does dose matter so much?

BPC-157 is a synthetic peptide made up of 15 amino acids. It’s derived from a protective protein found naturally in human gastric juice. The “BPC” stands for Body Protection Compound, which gives you a hint about what researchers think it does.

In animal studies, this peptide has shown some genuinely interesting effects. We’re talking accelerated healing of tendons, muscles, ligaments, and even the gut lining. It appears to work partly by promoting angiogenesis (the growth of new blood vessels) and by modulating growth factors involved in tissue repair.

Here’s why dosage matters more than you might think: peptides aren’t like vitamins where you can just take extra and pee out what you don’t need. They’re signaling molecules. Too little might do nothing. The right amount might trigger the healing cascade you’re looking for. And too much? We honestly don’t know, because human trials are essentially nonexistent.

The practical takeaway: you’re working with incomplete information, and that means being thoughtful about dosing rather than just copying what some guy on Reddit did.

What the animal studies actually used

Most of what we “know” about BPC-157 comes from rodent studies, and the dosing in those studies is surprisingly consistent. Researchers typically use somewhere between 10 mcg per kilogram of body weight on the low end and 50 mcg/kg on the high end. Some studies push up to 100 mcg/kg.

But here’s where it gets tricky. You can’t just multiply your weight in kilograms by these numbers and call it a day. Rodent metabolism runs much faster than ours. A mouse’s heart beats around 600 times per minute compared to your 60-100. They process substances differently.

Scientists use something called allometric scaling to convert doses between species. The most common method (FDA-approved for drug development, actually) suggests you divide a mouse dose by about 12.3 or a rat dose by about 6.2 to get a rough human equivalent.

Let’s do some quick math. If a study uses 10 mcg/kg in rats, the human equivalent dose would be around 1.6 mcg/kg. For a 70 kg person (about 154 pounds), that works out to roughly 112 mcg total. At the higher end of rat dosing (50 mcg/kg), you’d get a human equivalent around 560 mcg.

This is where the commonly cited doses of 250-500 mcg per day come from. They’re not pulled from thin air. They’re rough extrapolations from animal data.

The dosing approaches people actually use

Spend any time in peptide communities and you’ll see a few standard protocols floating around. None of these are medically approved or clinically validated, but they represent what the self-experimenting crowd has settled on through trial and error.

The conservative approach sits around 200-250 mcg once or twice daily. People typically use this for general recovery support or minor issues. The thinking: start low, see how you respond, minimize unknown risks.

The moderate approach lands at 250-300 mcg twice daily (so 500-600 mcg total). This seems to be the most common range for people dealing with specific injuries. They’re trying to balance effectiveness against the uncertainty of higher doses.

The aggressive approach pushes 500 mcg or more twice daily. You’ll see this with people treating stubborn injuries that haven’t responded to other interventions. Higher risk tolerance, higher potential reward, higher uncertainty.

Most people run these protocols for 4-12 weeks, then take a break. Some cycle it around training phases or injury recovery timelines.

One thing worth noting: people generally report that splitting the dose (morning and evening) works better than taking it all at once. The logic is that BPC-157 has a relatively short half-life, so more frequent dosing maintains steadier levels. Whether this actually matters remains unproven.

Injection vs. oral: does the route change the math?

This is where things get even murkier. BPC-157 is unusual among peptides because it appears to have some oral bioavailability. Most peptides get destroyed in your digestive system, but BPC-157 seems to survive at least partially intact.

The animal studies used both injection and oral administration, and both showed effects. But the doses weren’t equivalent. Oral doses in studies are often higher, presumably because some of the compound gets lost during digestion and absorption.

People using injectable BPC-157 typically stick to the ranges mentioned above. Those using oral forms often take 500-1000 mcg or more, reasoning that absorption might be only 10-20% of what they swallow.

There’s another consideration: where you inject might matter for localized injuries. Subcutaneous injection near an injury site is the most common approach. Some believe this delivers a higher local concentration where it’s needed most. Others argue that since BPC-157 appears to have systemic effects regardless of injection site, location doesn’t matter much.

The honest answer? We don’t have good data comparing these approaches in humans.

Does more actually work better?

This is the million-dollar question, and the frustrating answer is: we don’t know.

In animal studies, there’s often a dose-response relationship up to a point, then it plateaus. Higher doses don’t necessarily produce better outcomes. Some researchers have noted that very high doses don’t seem to cause obvious harm in animals, which is reassuring but doesn’t mean unlimited amounts are a good idea.

The anecdotal human reports are mixed. Some people claim they needed higher doses to see effects. Others say they got the same results from 250 mcg as from 500 mcg. Individual variation in absorption, metabolism, and the nature of the injury being treated all probably play a role.

What most experienced users seem to agree on: if you’re not seeing any response at moderate doses after 2-3 weeks, either the peptide isn’t going to work for your situation, or there’s a quality issue with your source. Doubling down on a non-responder situation rarely helps.

What about quality and actual dosing accuracy?

Here’s something that doesn’t get discussed enough. The peptide you buy might not contain what the label says. This is an unregulated market. Quality varies wildly between suppliers.

Some vials contain less than claimed. Some contain degraded product. A few contain contaminants. Third-party testing exists but isn’t universal. When your “500 mcg” might actually be 300 mcg or 700 mcg, all the careful dosing calculations become somewhat academic.

If you’re considering BPC-157, sourcing matters as much as dosing. Look for suppliers who provide certificates of analysis from independent labs. Check for purity percentages (99%+ is the standard). Ask about their testing protocols.

This isn’t about finding the “best” source. It’s about basic quality assurance in a market where the buyer has to do their own due diligence.

Making your own decision

BPC-157 sits in a strange regulatory and scientific gray zone. The animal data looks promising. Human clinical trials are basically nonexistent. Thousands of people use it anyway and share their experiences, creating a body of informal knowledge that’s helpful but not rigorous.

If you’re considering experimenting with this peptide, here’s how to think about dosage:

Start at the lower end of common ranges (200-250 mcg daily). Give it at least two weeks before adjusting. Pay attention to what you’re actually trying to achieve and whether you’re seeing any movement toward that goal. Keep notes, because memory is unreliable.

And be honest with yourself about the uncertainty involved. Anyone who tells you they know the “optimal” BPC-157 dosage is overstating their confidence. The best you can do is make informed decisions based on limited data, pay attention to your body’s response, and adjust accordingly.

If you’re dealing with a serious injury or health condition, that’s worth a conversation with a physician who’s open to discussing peptides. They exist, and having medical oversight isn’t weakness. It’s smart risk management.